Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Gao N, Yang RN, Meng Z, et al. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Biosci Rep. 2018;38:BSR20180686.
   PubMed Web of Science ®Google Scholar
• Lu R, Chen J, Kong L, et al. Prognostic value of lncRNA ROR expression in various cancers: a meta-analysis. Biosci Rep. 2018;38:BSR20181095.
   PubMed Web of Science ®Google Scholar
• Ou Y, Huang J, Yang L. The prognostic significance of pretreatment serum gamma-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review. Biosci Rep. 2018;38(6):BSR20181058.
   PubMed Web of Science ®Google Scholar
• Peng Y, Huang D, Ma K, et al. MiR-19a as a prognostic indicator for cancer patients: a meta-analysis. Biosci Rep. 2019;39(5):BSR20182370.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen K, Liu H, et al. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis. Biosci Rep. 2019;39(1):BSR20180618.
   PubMed Web of Science ®Google Scholar
• Miki T, Smith CL, Long JE, et al. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature. 1993;362(6419):462–465.
   PubMed Web of Science ®Google Scholar
• Niiya F, Tatsumoto T, Lee KS, et al. Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA. Oncogene. 2006;25(6):827–837.
   PubMed Web of Science ®Google Scholar
• Tatsumoto T, Xie X, Blumenthal R, et al. Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol. 1999;147(5):921–928.
   PubMed Web of Science ®Google Scholar
• Baker MJ, Cooke M, Kazanietz MG. Nuclear PKCiota-ECT2-Rac1 and ribosome biogenesis: a novel axis in lung tumorigenesis. Cancer Cell. 2017;31(2):167–169.
   PubMed Web of Science ®Google Scholar
• Luo Y, Qin SL, Mu YF, et al. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Biomed Pharmacother. 2015;73:135–139.
   PubMed Web of Science ®Google Scholar
• Kim JG, Kim MJ, Choi WJ, et al. Wnt3A induces GSK-3beta phosphorylation and beta-catenin accumulation through RhoA/ROCK. J Cell Physiol. 2017;232(5):1104–1113.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ma Z, Zou W, et al. N-myc downstream-regulated gene 2 controls astrocyte morphology via Rho-GTPase signaling. J Cell Physiol. 2019;234(11):20847–20858.
   PubMed Web of Science ®Google Scholar
• Bustelo XR. RHO GTPases in cancer: known facts, open questions, and therapeutic challenges. Biochem Soc Trans. 2018;46(3):741–760.
   PubMed Web of Science ®Google Scholar
• Bai X, Yi M, Xia X, et al. Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA. Cancer Manag Res. 2018;10:4039–4050.
   PubMed Web of Science ®Google Scholar
• Daulat AM, Finetti P, Revinski D, et al. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer. Br J Cancer. 2019;120(9):931–940.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cai O, Wu P, et al. MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2. J Cell Biochem. 2019;120(1):967–976.
   PubMed Web of Science ®Google Scholar
• Zhi T, Jiang K, Xu X, et al. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1. Neuro Oncol. 2019;21(4):462–473.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu J, Zhang Y. Role of epithelial cell transforming sequence 2 (ECT2) in predicting prognosis of osteosarcoma. Med Sci Monit. 2017;23:3861–3868.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Lin C, Cheng YP, et al. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas. Neurol India. 2014;62:406–409.
   PubMed Web of Science ®Google Scholar
• Iyoda M, Kasamatsu A, Ishigami T, et al. Epithelial cell transforming sequence 2 in human oral cancer. PLoS One. 2010;5(11):e14082.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yu Y, Shao Q, et al. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients. Int J Clin Exp Pathol. 2014;7(12):8724–8731.
   PubMed Web of Science ®Google Scholar
• Liu B, Yang H, Taher L, et al. Identification of prognostic biomarkers by combined mRNA and miRNA expression microarray analysis in pancreatic cancer. Transl Oncol. 2018;11(3):700–714.
   PubMed Web of Science ®Google Scholar
• Wang HK, Liang JF, Zheng HX, et al. Expression and prognostic significance of ECT2 in invasive breast cancer. J Clin Pathol. 2018;71(5):442–445.
   PubMed Web of Science ®Google Scholar
• Zhou S, Wang P, Su X, et al. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. PLoS One. 2017;12(10):e0187356.
   PubMed Web of Science ®Google Scholar
• Yang W, Wan H, Shan R, et al. The clinical significance and prognostic value of Xenopus kinesin-like protein 2 expressions in human tumors: a systematic review and meta-analysis. J Cell Physiol. 2019 Feb 18. Doi: 10.1002/jcp.28343. [Epub ahead of print].
   Web of Science ®Google Scholar
• Mohammadi M, Mianabadi F, Mehrad-Majd H. Circulating visfatin levels and cancers risk: a systematic review and meta-analysis. J Cell Physiol. 2019;234(4):5011–5022.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xu P, Liu K, et al. Hyperuricemia and gout are associated with cancer incidence and mortality: a meta-analysis based on cohort studies. J Cell Physiol. 2019;234(8):14364–14376.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu W, Xu J. Prognostic utility and clinical significance of lysyl oxidase-like 2 protein expression in digestive system cancers. J Cell Physiol. 2019;234(11):20713–20720.
   PubMed Web of Science ®Google Scholar
• Hirata D, Yamabuki T, Miki D, et al. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin Cancer Res. 2009;15(1):256–266.
   PubMed Web of Science ®Google Scholar
• Kosibaty Z, Murata Y, Minami Y, et al. Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression. Lab Invest. 2019;99(4):551–567.
   PubMed Web of Science ®Google Scholar
• Murata Y, Minami Y, Iwakawa R, et al. ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer Sci. 2014;105(4):490–497.
   PubMed Web of Science ®Google Scholar
• Sano M, Genkai N, Yajima N, et al. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep. 2006;16:1093–1098.
   PubMed Web of Science ®Google Scholar
• Shi YX, Yin JY, Shen Y, et al. Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer. Sci Rep. 2017;7(1):8072.
   PubMed Web of Science ®Google Scholar
• Chen J, Xia H, Zhang X, et al. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma. J Hepatol. 2015;62(6):1287–1295.
   PubMed Web of Science ®Google Scholar
• Guo Z, Chen X, Du T, et al. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. Med Oncol. 2017;34(1):13.
   PubMed Web of Science ®Google Scholar
• Wang HB, Yan HC, Liu Y. Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients. Clin Transl Oncol. 2016;18(7):735–742.
   PubMed Web of Science ®Google Scholar
• Xiu Y, Liu W, Wang T, et al. Overexpression of ECT2 is a strong poor prognostic factor in ER+ breast cancer. Mol Clin Onc. 2019;10:497–505.
   PubMed Web of Science ®Google Scholar
• Li Y, Cai X, Chen B, et al. Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis. Exp Ther Med. 2017;14:4862–4868.
   PubMed Web of Science ®Google Scholar
• Salhia B, Tran NL, Chan A, et al. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol. 2008;173(6):1828–1838.
   PubMed Web of Science ®Google Scholar
• Zhi T, Jiang K, Xu X, et al. MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1. Am J Transl Res. 2017;9(11):4872–4887.
   PubMed Web of Science ®Google Scholar
• Tan H, Wang X, Yang X, et al. Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells. Exp Ther Med. 2016;12(4):2088–2094.
   PubMed Web of Science ®Google Scholar
• Caggia S, Chunduri H, Millena AC, et al. Novel role of Gialpha2 in cell migration: downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells. J Cell Physiol. 2019;234(1):802–815.
   Web of Science ®Google Scholar
• Zanca C, Cozzolino F, Quintavalle C, et al. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. J Cell Physiol. 2010;225(1):63–72.
   PubMed Web of Science ®Google Scholar
• Lou S, Wang P, Yang J, et al. Prognostic and clinicopathological value of Rac1 in cancer survival: evidence from a meta-analysis. J Cancer. 2018;9(14):2571–2579.
   PubMed Web of Science ®Google Scholar
• Fortin SP, Ennis MJ, Schumacher CA, et al. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Mol Cancer Res. 2012;10(7):958–968.
   PubMed Web of Science ®Google Scholar
• Weeks A, Okolowsky N, Golbourn B, et al. ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells. Am J Pathol. 2012;181(2):662–674.
   PubMed Web of Science ®Google Scholar
• Huff LP, Decristo MJ, Trembath D, et al. The role of Ect2 nuclear RhoGEF activity in ovarian cancer cell transformation. Genes Cancer. 2013;4(11–12):460–475.
   PubMedGoogle Scholar
• Murray NR, Kalari KR, Fields AP. Protein kinase Ciota expression and oncogenic signaling mechanisms in cancer. J Cell Physiol. 2011;226(4):879–887.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hill KS, Fields AP. PKCiota maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. Mol Cancer Res. 2013;11(12):1624–1635.
   PubMed Web of Science ®Google Scholar
• Justilien V, Ali SA, Jamieson L, et al. Fields, Ect2-dependent rRNA synthesis is required for KRAS-TRP53-driven lung adenocarcinoma. Cancer Cell. 2017;31(2):256–269.
   PubMed Web of Science ®Google Scholar
• Fang ZQ, Li MC, Zhang YQ, et al. MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2. J Cell Biochem. 2018;119(10):8317–8324.
   PubMed Web of Science ®Google Scholar
• Xu J, Yao Q, Hou Y, et al. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation. Biomed Pharmacother. 2013;67(5):381–386.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian P, Liu Y. P53 and protein phosphorylation regulate the oncogenic role of epithelial cell transforming 2 (ECT2). Med Sci Monit. 2017;23:3154–3160.
   PubMed Web of Science ®Google Scholar
• Mansour M, Haupt S, Chan AL, et al. The E3-ligase E6AP represses breast cancer metastasis via regulation of ECT2-rho signaling. Cancer Res. 2016;76(14):4236–4248.
   PubMed Web of Science ®Google Scholar